Atlas Trials

Effects Of Sodium Glucose Cotranspoter 2 Inhibitors On Heart And Kidneys In Fabry Disease Patients

Clinical trial NCT05710367 · UNKNOWN

Trial details

NCT number
NCT05710367
Sponsor
Albina Nowak, MD
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2023-08-01
Primary completion
2024-08-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.